More remyelination research
For years, most MS research has focused on stopping disease progression. In the past couple years, however, more and more researchers have been focusing on whether it’s possible to fix the damage MS has already done. They’re trying to find a way to repair the myelin coating of our nerves.
The latest of these is efforts is sponsored by Frequency Therapeutics, as MS News Today‘s Margarida Maia reports in “Frequency moving to test agents with remyelination potential.” Frequency hopes to launch a clinical trial by June 2024. It can’t come soon enough for people like me with significant myelin damage.
Improving brain cell function
One of the less visible problems that occurs with MS is disease progression that is independent of relapse activity. Many disease-modifying therapies can help to slow disease progression by reducing inflammation.
A story by Marisa Wexler, “CNM-Au8 preserves white matter in RRMS patients’ brains: Phase 2 trial,” reports on the testing of a compound that’s designed to help people with MS by improving the functioning of nerve cells in the brain.
Keeping those bones strong
One possible solution to bone density concerns is diet, particularly increasing one’s calcium intake. Does it matter, though, whether you’re being helped by a dietitian while trying to boost that intake?
Find the answer in “Dietitian advice assists MS patients to improve calcium intake: Trial.” I’ve taken calcium pills for years, so no dietitian was needed. Have you done anything to increase your calcium levels? Have you ever used a dietitian? Please share in the comments below.
Note: Multiple Sclerosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis, or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. The opinions expressed in this column are not those of Multiple Sclerosis News Today or its parent company, BioNews, and are intended to spark discussion about issues pertaining to multiple sclerosis.
Click for source of this article
Click to Subscribe for the MS Beacon eNewsletter, resources and MS educational events